longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Edesa Biotech(EDSA.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watch

rttnews·9 Hours ago
US
ADIL
+4.85%
US
BDTX
+16.33%
US
EDSA
-8.95%
rttnews·9 Hours ago
US
ADIL
+4.85%
US
BDTX
+16.33%
US
EDSA
-8.95%

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga_article·Yesterday at 01:06
US
AMIX
+23.34%
US
WOK
-20.85%
US
MTVA
+54.79%
benzinga_article·Yesterday at 01:06
US
AMIX
+23.34%
US
WOK
-20.85%
US
MTVA
+54.79%

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference | EDSA Stock News

StockTitan·Yesterday at 13:15
US
EDSA
-8.95%
US
BIB
+4.36%
US
LABU
+10.43%
StockTitan·Yesterday at 13:15
US
EDSA
-8.95%
US
BIB
+4.36%
US
LABU
+10.43%

Edesa Biotech | 8-K: FY2026 Q2 Revenue: USD 0

Earnings Watch·05/15/2026 04:53
US
EDSA
-8.95%
Earnings Watch·05/15/2026 04:53
US
EDSA
-8.95%

Pre-market hot trades in US stocks: Edesa Biotech up 9.27% in pre-market; Aehr Test up 7.20% in pre-market

Price Alert·05/13/2026 18:02
US
EDSA
-8.95%
US
AEHR
+2.53%
Price Alert·05/13/2026 18:02
US
EDSA
-8.95%
US
AEHR
+2.53%
© 2026 Longbridge|Disclaimer

Event Tracking

May15
Edesa Biotech released FY2026 Q2 earnings on May 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4938 (forecast USD -0.26)
03:00
Feb14
Edesa Biotech released FY2026 Q1 earnings on February 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2819 (forecast USD -0.45)
04:00
Dec13
Edesa Biotech released FY2025 Q4 earnings on December 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3158 (forecast USD -0.2666)
04:00
Edesa Biotech released FY2025 annual earnings on December 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.2657 (forecast USD -1.17)
04:00
Oct29
Edesa Biotech's EB05 Shows Positive Results in Phase 3 Clinical Trials for ARDS
10:21
Sep30
Edesa Biotech Inc. revises financing agreement with the Canadian government for ARDS drug development
20:15

Schedules & Filings

Schedules
Filings
May14
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Net Income -4.218 M, EPS -0.4938

Feb13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -2.248 M, EPS -0.2819

Dec12
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -2.228 M, EPS -0.3158

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
5.850
+2,387.24%
+5.565
HCWB
2.650
+150.00%
+1.590
GCL
0.8772
+103.20%
+0.445
SLXN
0.4807
+78.70%
+0.212
MWC
7.755
+64.30%
+3.060
PHGE
0.5966
+59.52%
+0.223
VIDA
3.605
+57.42%
+1.315
MTVA
2.910
+54.79%
+1.030
MLGO
5.910
+54.31%
+2.080
XNDX
21.140
+44.79%
+6.540
View More